ALK-Abelló A/S ( AKBLF) - Stock Earnings
AKBLF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 20, 2026 AfterMarket | — / — | — | — / — | — |
AKBLF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 49.4 million USD | 240.5 million USD |
| 2025Q4 | 41.7 million USD | 271.8 million USD |
| 2026Q1 | 67.1 million USD | 271.9 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AKBLF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 71.9 million USD | 714.2 million USD |
| 2024 | 113.8 million USD | 773.1 million USD |
| 2025 | 187.7 million USD | 989.8 million USD |
| 2026 Est. | — | — |
AKBLF
Price: $38.89
Dividend Yield: 0.64%
Forward Dividend Yield: 0.65%
Dividend Per Share: 0.25 USD
Earnings Per Share: 0.91 USD
P/E Ratio: 39.07
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 1